Search Results - Steele, J.P.C

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)

    Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM) by Klabatsa, A., Sheaff, M.T., Steele, J.P.C., Evans, M.T., Rudd, R.M., Fennell, D.A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    84 Spontaneous regression of diffuse malignant pleural mesothelioma with no treatment: Two case reports

    84 Spontaneous regression of diffuse malignant pleural mesothelioma with no treatment: Two case reports by Klabatsa, A., Sheaff, M.T., Steele, J.P.C., Rudd, R.M., Fennell, D.A.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    247 Spontaneous regression of diffuse malignant pleural mesothelioma (MPM) with no treatment: Two case reports

    247 Spontaneous regression of diffuse malignant pleural mesothelioma (MPM) with no treatment: Two case reports by Klabatsa, A., Sheaff, M.T., Steele, J.P.C., Rudd, R.M., Fennell, D.A.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

    221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma by Szlosarek, P.W., Fennell, D.A., Rudd, R.M., Lind, M., Ranson, M., Hackshaw, A., Bomalaski, J.S., Steele, J.P.C.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    100 Bax and Bak immunoreactivity in malignant pleural mesothelioma (MPM)

    100 Bax and Bak immunoreactivity in malignant pleural mesothelioma (MPM) by Klabatsa, A., Bax, S., Steele, J.P.C., Rudd, R.M., Sheaff, M.T., Fennell, D.A.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    114 Phase II trial of vinorelbine chemotherapy in patients with malignant peritoneal mesothelioma

    114 Phase II trial of vinorelbine chemotherapy in patients with malignant peritoneal mesothelioma by Steele, J.P.C., Klabatsa, A., Fennell, D.A., Bowen, R.L., Sheaff, M.T., Reznek, R.A., Rudd, R.M.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    The new front line treatment for malignant pleural mesothelioma?

    The new front line treatment for malignant pleural mesothelioma? by Steele, J P C

    Published in Thorax
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma

    Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma by Steele, J.P.C, Shamash, J, Evans, M.T, Gower, N.H, Rudd, R.M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Vinorelbine (Navelbine) given as a single agent for malignant pleural mesothelioma. Results from 65 patients at a single centre

    Vinorelbine (Navelbine) given as a single agent for malignant pleural mesothelioma. Results from 65 patients at a single centre by Steele, J.P.C, Shamash, J, Gower, N.H, Evans, M.T, Tischkowitz, M.D, Rudd, R.M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: